Concepedia
Statistics
Publications
53
Citations
4.1K
H-Index
35
Active since
1998
Affiliations
OptiNose (United States)(Current)
Janssen (United States)
OptiNose (Norway)
Janssen Scientific Affairs (United States)
Johnson & Johnson (United States)
Ramy Mahmoud is an author at OptiNose (United States) specializing in medicine, psychiatry, and social sciences.
Top concepts
MedicinePsychiatryPsychopathologySocial SciencesSchizophreniaPsychopharmacologyMental HealthPharmacotherapyNeuroscienceHealth Policy
Publications per year
1998–2024
Anticholinergic Activity of 107 Medications Commonly Used by Older Adults
Marci L. Chew, Benoit H. Mulsant, Bruce G. Pollock et al. · Journal of the American Geriatrics Society · 2008 · 486 citations
Geriatric Psychiatry, Medicinal Chemistry, Overall Anticholinergic Burden +14
A Randomized Double-Blind Study of Risperidone and Olanzapine in the Treatment of Schizophrenia or Schizoaffective Disorder
Robert R. Conley, Ramy Mahmoud · American Journal of Psychiatry · 2001 · 333 citations
Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes
Frank D. Gianfrancesco, Amy Grogg, Ramy Mahmoud et al. · The Journal of Clinical Psychiatry · 2002 · 237 citations
Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
Richard Payne, Susan D. Mathias, David J. Pasta et al. · Journal of Clinical Oncology · 1998 · 227 citations
Effects of Behavioral Therapy on Weight Loss in Overweight and Obese Patients With Schizophrenia or Schizoaffective Disorder
Jaspreet S. Brar, Rohan Ganguli, Gahan Pandina et al. · The Journal of Clinical Psychiatry · 2005 · 177 citations
1–5 of 53